Literature DB >> 2180360

Long-term survival following nodal metastases from basal cell carcinoma.

R L Raszewski1, B Guyuron.   

Abstract

A case of long-term survival with metastatic basal cell carcinoma to regional lymph nodes is presented. The literature has been briefly reviewed. When a metastatic basal cell carcinoma is discovered, the average survival is only 8 to 10 months. The patient in this case report has been followed for 10 years from the initial metastatic discovery and 7 years from the last metastatic surgery by one of the authors. There has been no evidence of recurrent disease. The topic of metastatic basal cell carcinoma is detailed in this report.

Entities:  

Mesh:

Year:  1990        PMID: 2180360     DOI: 10.1097/00000637-199002000-00012

Source DB:  PubMed          Journal:  Ann Plast Surg        ISSN: 0148-7043            Impact factor:   1.539


  8 in total

1.  Cervical in-transit metastasis from a truncal basal cell carcinoma.

Authors:  Muhammad Kamaal Khan; Steven Powell; Neil Cox; Andrew Robson; Nick Murrant
Journal:  BMJ Case Rep       Date:  2010-07-21

Review 2.  Safety and Tolerability of Sonic Hedgehog Pathway Inhibitors in Cancer.

Authors:  Richard L Carpenter; Haimanti Ray
Journal:  Drug Saf       Date:  2019-02       Impact factor: 5.606

3.  Vismodegib (erivedge) for advanced Basal cell carcinoma.

Authors:  Chris Fellner
Journal:  P T       Date:  2012-12

4.  Systemic therapy for inoperable and metastatic basal cell cancer.

Authors:  Leslie A Fecher
Journal:  Curr Treat Options Oncol       Date:  2013-06

5.  Metastatic Basal cell carcinoma: a case report and review of the literature.

Authors:  Anthony Vu; Donald Laub
Journal:  Eplasty       Date:  2011-04-29

6.  The management of non-melanocytic skin malignancies of the scalp and calvarium.

Authors:  Harun Cöloğlu; Burak Ozkan; Mesut Sener; Ahmet Çağrı Uysal; Hüseyin Borman
Journal:  Indian J Plast Surg       Date:  2014-01

7.  Long-term efficacy and safety of sonidegib in patients with locally advanced and metastatic basal cell carcinoma: 30-month analysis of the randomized phase 2 BOLT study.

Authors:  J T Lear; M R Migden; K D Lewis; A L S Chang; A Guminski; R Gutzmer; L Dirix; P Combemale; A Stratigos; R Plummer; H Castro; T Yi; M Mone; J Zhou; U Trefzer; M Kaatz; C Loquai; R Kudchadkar; D Sellami; R Dummer
Journal:  J Eur Acad Dermatol Venereol       Date:  2017-11-06       Impact factor: 6.166

Review 8.  Advanced basal cell carcinoma, the hedgehog pathway, and treatment options - role of smoothened inhibitors.

Authors:  Leslie A Fecher; William H Sharfman
Journal:  Biologics       Date:  2015-11-06
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.